Patients sought for clinical trials of the rare blood disease, a randomized phase, 18 years of, answer a few

  • Published date: Jul 13, 2015
    • Fort Washington, United States
Patients sought for clinical trials of the rare blood disease, a randomized phase, 18 years of, answer a few

NPatients with intermediate-1 or -2 or high-risk myelofibrosis are sought for a comparative clinical trial in the George Washington University Medical Faculty Associates of Washington, DC NGeorge Washington University Medical Faculty Associates and other hospitals in the US . They are participating with a goal to enroll approximately 300 participants. The study is designed to evaluate a potential new treatment option for patients with myelofibrosis who have abnormally low platelet counts, also known as thrombocytopenia. Neste is a randomized phase 3 study assessing oral pacritinib research against the best treatment available for patients with thrombocytopenia and primary myelofibrosis, post-polycythemia vera myelofibrosis or post-thrombocythemia myelofibrosis essential. Nthose eligible for the study must be 18 years of age or older and have intermediate-1 or -2 or high-risk myelofibrosis. NFor more information and to see if you or someone you know may be eligible for the PERSIST-2 study visit PERSISTProgram.com and answer a few quick questions, or visit clinicaltrials.gov and use identifier NCT02055781. N

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings